About 3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide
3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide (PubChem CID 113051729) has the molecular formula C17H17N5O2
and a molecular weight of 323.36 g/mol. Its IUPAC name is 3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide.
Analyze 3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide?
The IUPAC name of 3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide (CID 113051729) is 3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide.
What is the SMILES notation for 3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide?
The canonical SMILES for 3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide is Cc1cc(Nc2ccc(NC(=O)c3ccc(C)c(C)c3)nn2)no1.
What is the InChIKey of 3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide?
The InChIKey is XVALAQBRIWPTJB-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H17N5O2/c1-10-4-5-13(8-11(10)2)17(23)19-15-7-6-14(20-21-15)18-16-9-12(3)24-22-16/h4-9H,1-3H3,(H,18,20,22)(H,19,21,23).
What are the key properties of 3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide?
3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide has a molecular weight of 323.36 g/mol, XLogP of 3.39, 4 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3,4-dimethyl-N-[6-[(5-methyl-1,2-oxazol-3-yl)amino]pyridazin-3-yl]benzamide is sourced from PubChem (CID 113051729), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).